|
|
||||||||
Published online before print August 21, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
@
*Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, and
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia
@ To whom correspondence should be addressed. E-mail: collmanr{at}mail.med.upenn.edu.
| Abstract |
|---|
HIV-1 infection of cells is mediated by engagement between viral envelope glycoproteins (Env) and a receptor complex comprising CD4 and one of two chemokine receptors, CCR5 and CXCR4, expressed on the surface of target cells. Most CD4+-transformed T cell lines express only CXCR4, but primary lymphocytes and macrophages, the main cellular targets for infection in vivo, express both coreceptors. Cell- and viral strain-specific utilization of these coreceptor pathways, rather than coreceptor expression per se, regulates lymphocyte and macrophage entry and tropism. Virus use of coreceptor[s] (R5, X4, or R5 and X4) and its target cell tropism (lymphocytes, macrophages, and/or transformed T cell lines) are related but distinct characteristics of Envs. A comprehensive classification schema of HIV-1 Env phenotypes that addresses both tropism and coreceptor use is proposed. Defining Env phenotype based on both parameters is important in the development of entry inhibitors and vaccines, for understanding changes in Env that evolve over time in vivo, and for discerning differences among viral species that underlie aspects of pathogenesis and transmission. Recognizing how tropism is related to, yet differs from, coreceptor selectivity is critical for understanding the mechanisms by which these viral characteristics impact pathogenesis.
Key Words: HIV-1 entry CCR5 CXCR4 host cell tropism envelope HIV-1 phenotype HIV-1 classification review
This article has been cited by other articles:
![]() |
J. E. Harrison, J. B. Lynch, L.-J. Sierra, L. A. Blackburn, N. Ray, R. G. Collman, and R. W. Doms Baseline Resistance of Primary Human Immunodeficiency Virus Type 1 Strains to the CXCR4 Inhibitor AMD3100 J. Virol., December 1, 2008; 82(23): 11695 - 11704. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coetzer, R. Nedellec, J. Salkowitz, S. McLaughlin, Y. Liu, L. Heath, J. I. Mullins, and D. E. Mosier Evolution of CCR5 Use before and during Coreceptor Switching J. Virol., December 1, 2008; 82(23): 11758 - 11766. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Montaner, S. M. Crowe, S. Aquaro, C.-F. Perno, M. Stevenson, and R. G. Collman Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs J. Leukoc. Biol., November 1, 2006; 80(5): 961 - 964. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |